Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis

Chinese Journal of Cancer

Volumn 29, Issue 4, 2010, Pages 431-435

  Huang, Long ^a,b   Zheng, Min ^a,b   Liu, Jihong ^a,b   Xiong, Ying ^a,b   Ding, Hui ^a,b   Tang, Li ^a,b   Wang, Huiyun ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cervlcal cancer; Common lllac lymph node; Metastasls; Prognosls; Risk factors

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HYSTERECTOMY; ILIAC LYMPH NODE METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

EID: 79955828163     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10360     Document Type: Article

References (10)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2):74-108.
2. Schiffman M, Castle PE, Jeronimo J,et al. Human papillomavi-ru s and cervical cancer[J]. Lancet, 2007, 370:890-907.
3. Monk B J, Cha D S, Walker J L, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IA cervical carcinoma[J]. Gynecol Oncol, 1994, 54(1):4-9.
4. Sakuragi N, Satoh C, Takeda N et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, II A and II B cervical carcinoma treated with radical hysterectomy[J]. Cancer,1999,85(7):1547-1554.
5. Aoki Y, Sasaki M, Watanabe M, et al. High-ris k group in node-po sitive patients with stage IB, II A, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation [J]. Gynecol Oncol, 2000, 77:305-309.
6. Yeh SA, Leung SW, Wang CJ, et al. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors [J]. Gynecol Oncol, 1999, 72(1):10-15.
7. Kodaira T, Fuwa N, Nakanishi T, et a1. Long-te rm clinical outcomes of postoperative pelvic radiotherapy with or without prophylactic paraaortic irradiation for stage I -II cervical carcinoma with positive lymph nodes [J]. Am J Clin Oncol, 2004, 27 (2):140-148.
8. Takeshima N, Hirai Y, Katase K, et a1. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer [J]. Gynecol Oncol, 1998, 68 (3):263 -266.
9. Feng SY, Zhang YN, Liu JG, et al. Risk factors and prognosis of node- positive cervical carcinoma [J]. Chinese Journal of Cancer, 2005, 24(10): 1261-1266.
10. Cheng X, Cai SM, Li ZT, et al. Prognosis of patients with stage IB-IIB node positvie cervical carcinoma [J]. Chinese Journal of Cancer, 2003, 22(11): 1219-1223.